Does Rivastigmine Improve Cognitive Functions or Disability in Patients with Alzheimer’s Disease? | Zendy

Teresa Anna Cantisani | Zendy; Maria Grazia Celani | Zendy; Enrico Righetti | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does Rivastigmine Improve Cognitive Functions or Disability in Patients with Alzheimer’s Disease?

Author(s) -

Teresa Anna Cantisani,

Maria Grazia Celani,

Enrico Righetti

Publication year - 2004

Publication title -

neuroepidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.217

H-Index - 87

eISSN - 1423-0208

pISSN - 0251-5350

DOI - 10.1159/000078507

Subject(s) - rivastigmine , medicine , disease , cognition , dementia , alzheimer's disease , donepezil , psychiatry , physical medicine and rehabilitation

Data Source We evaluated the Cochrane systematic review of randomised controlled trials [1]. Trials were identified by searching Medline, Embase, Central Cochrane Library, Cochrane Dementia and Cognitive Improvement Group database, abstract from proceedings of the main Dementia Conferences, and by contacting the pharmaceutical company, Novartis, for unpublished and published trials. The search was updated to December 2000.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research